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Abstract
Experimental and clinical data demonstrate that atrial fibrillation (AF) maintenance in animals and 
groups of patients depends on localized reentrant sources localized primarily to the pulmonary 
veins (PVs) and the left atrium(LA) posterior wall in paroxysmal AF but elsewhere, including the 
right atrium (RA), in persistent AF. Moreover, AF can be eliminated by directly ablating AF-
driving sources or “rotors,” that exhibit high-frequency, periodic activity. The RADAR-AF 
randomized trial demonstrated that an ablation procedure based on a more target-specific strategy 
aimed at eliminating high frequency sites responsible for AF maintenance is as efficacious as and 
safer than empirically isolating all the PVs.
In contrast to the standard ECG, global atrial noninvasive frequency analysis allows non-invasive 
identification of high-frequency sources before the arrival at the electrophysiology laboratory for 
ablation. Body surface potential map (BSPM) replicates the endocardial distribution of DFs with 
localization of the highest DF (HDF) and can identify small areas containing the high-frequency 
sources. Overall, BSPM had a sensitivity of 75% and specificity of 100% for capturing 
intracardiac EGMs as having LARA DF gradient. However, raw BSPM data analysis of AF 
patterns of activity showed incomplete and instable reentrant patterns of activation. Thus, we 
developed an analysis approach whereby a narrow band-pass filtering allowed selecting the 
electrical activity projected on the torso at the HDF, which stabilized the projection of rotors that 
potentially drive AF on the surface. Consequently, driving reentrant patterns (“rotors”) with 
spatiotemporal stability during >70% of the AF time could be observed noninvasibly after HDF-
filtering. Moreover, computer simulations found that the combination of BSPM phase mapping 
with DF analysis enabled the discrimination of true rotational patterns even during the most 
complex AF. Altogether, these studies show that the combination of DF analysis with phase maps 
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of HDF-filtered surface ECG recordings allows noninvasive localization of atrial reentries during 
AF and further a physiologically-based rationale for personalized diagnosis and treatment of 
patients with AF.
Keywords
Atrial fibrillation; Body surface mapping; Rotors; Dominant frequency Fourier transform; Phase 
mapping
Introduction
Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice and is 
associated with increased risk of stroke, heart failure and death.1 Although antiarrhythmic 
drugs have limited efficacy, the demonstration of AF triggers in the atrial sleeves of the 
pulmonary veins (PVs) has led to a significant improvement in therapy.2, 3
Several ablative strategies have been developed with the objective of creating 
circumferential lesions around the PV ostia.4 Empiric circumferential pulmonary vein 
isolation (CPVI) is effective in ~70-80% of patients with paroxysmal AF and has become 
therapy of choice for drug-refractory AF in these patients.5 However, results still remain 
suboptimal due to the presence of non-PV sources maintaining AF.4, 6, 7 Moreover, the 
success rate of CPVI in the more prevalent persistent and long-lasting AF populations is 
significantly lower and extensive substrate based ablation strategies have been used with 
conflicting results.8, 9
Experimental and clinical data from our laboratory support the hypothesis that both acute 
and persistent AF in the sheep and some groups of human patients is not a random 
phenomenon. Studies analyzing the spatiotemporal organization of waves and dominant 
frequency (DF) in the isolated sheep heart demonstrate that AF maintenance in this model 
depends on localized reentrant sources in the left atrium (LA) and fibrillatory conduction in 
its periphery.10-15As a natural consequence of these studies, we translated the analysis on 
the organization of DF to human AF and found that AF reentrant sources are localized 
primarily to the PVs and LA posterior wall in the case of paroxysmal AF but elsewhere in 
the case of persistent AF.16-20 Several of these observational studies showed that AF could 
be eliminated by directly ablating AF-driving sources or “rotors,” that exhibit high-
frequency, periodic activity, based on either electrogram visual analysis, dominant 
frequency analysis or panoramic endocardial mapping.2, 17-19, 21-25 Recently the first 
randomized clinical trial, RADAR-AF, demonstrated that in paroxysmal AF patients, 
selective ablation of sites responsible for AF maintenance is as effective as CPVI, and 
decreased ablation risks.26 These results demonstrate that a an ablation procedure based on a 
more target-specific strategy aimed at eliminating high frequency sites responsible for AF 
maintenance is as efficacious and safer than empirically isolating all the PVs.
Therefore, it would be arguably desirable to noninvasibly both identify the location of the 
sources responsible for AF maintenance before the procedure in order to design the ideal 
ablation strategy for each individual AF patient as well as to be able to perform a panoramic 
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real-time localization of sources during the procedure.27, 28 Although the highest frequency 
sources in paroxysmal AF are most commonly located in the junction of the left atrium with 
the PVs, they have also been identified elsewhere in the atria and may shift in time. Recent 
studies by our group have shown that panoramic, global, atrial noninvasive frequency 
analysis is feasible in AF patients and may allow the identification of high-frequency 
sources before the arrival at the electrophysiology laboratory for ablation. Body surface map 
(BSPM) replicates the endocardial distribution of DFs and can identify small areas 
containing the high-frequency sources that result in fibrillatory conduction to the reminder 
of the atria, and may decrease the time required for the search and elimination of the highest 
DF (HDF) site.29 Moreover, we recently have shown that phase maps of surface potentials 
during AF after HDF-filtering allow observing driving reentrant patterns (“rotors”)with 
spatiotemporal stability during >70% of the AF time.30Thus, as will be shown in the 
following sections, the ability of BSPM to detect site(s) driving AF may enable a 
noninvasive personalized diagnosis and treatment of patients with AF.
The non-invasive mapping system
In our studies, AF patients wore a custom-made, adjustable vest with 64 electrodes covering 
the entire torso surface (Figure 1) during the ablation procedure.17, 29, 30 The vest included 
recording electrodes on the anterior (N=28), posterior (N=34) and lateral sides (N=2) of the 
torso. In addition, three limb leads were recorded and used to generate the Wilson Terminal. 
The BSPM vest was placed prior to the catheterization and fastened anteriorly, allowing 
access to the patient chest in case external electrical cardioversion was needed during the 
course of the study. Surface unipolar electrocardiographic recordings were obtained by 
using a commercial system for bio-potential measurements (Active Two, Biosemi, The 
Netherlands) at a sampling frequency of 2048 Hz and stored on hard disk for off-line 
analyses.31 Ventricular activity was removed from the unipolar recordings prior to analysis 
either numerically, or by application of adenosine.29
Spectral analysis of body surface potential mapping
Previous studies have highlighted the major role of maximal DF (DFmax) sources in the 
maintenance of AF in animals and humans.14, 17, 32 Arguably, prior knowledge of which 
atrium harbors the DFmax source that maintains the arrhythmia may allow better planning 
of the ablation procedure, and may accelerate the intracardiac localization of the highest DF 
point and reduce ablation time. Thus we explored the ability of the body surface DFs to 
capture the intracardiac DFmax.
Surface leads and simultaneously recorded intracardiac signals presented closely related 
spectral components. In Figure 2 we present spectral analyses of data from a representative 
patient in whom the presence of distinct atrial site with high-frequency activity in the 
posterior LA could be determined noninvasively. In Figure 2A, three representative EGMs 
illustrate the range of activation rates across the atria, with DFs ranging from 5.75 Hz in the 
RA to 7 Hz in the LA near the left superior pulmonary vein (LSPV). Simultaneously 
recorded surface leads also showed different DFs at nearly the same frequency range found 
in the EGM recordings, as shown in Figure 2B by three representative leads corresponding 
to the surface left (SL), surface posterior (SP) and surface right (SR) regions. Surface DFs 
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mostly correlated with the activation rate of nearest atrial tissue: the highest endocardial DF 
point was observed at the nearest point on the torso surface (central posterior) and the lowest 
activation rate of the RA was found at the nearest portion of the surface ECG (right inferior). 
Intracardiac CARTO DF maps obtained prior to adenosine infusion and surface DF 
distributions obtained during adenosine infusion showed good correspondence (Figure 2C 
and 2D), but a direct comparison of frequencies from CARTO and surface maps was 
unattainable due to its sequential nature and because adenosine accelerates AF activation in 
humans.18.
In panels A and B of Figure 3, we display difference maps obtained by subtracting DF 
values on the surface map from the intracardiac DFmax in patients from Figures 2 and 
another patient in which the DFmax resides in the RA. In each case, the white arrow points 
to the red color DFmax domain on the surface, which corresponds to the region with zero 
difference with the intracardiac DFmax. These examples demonstrate that the surface 
DFmax can accurately detect the value of the intracardiac DFmax value, regardless of 
whether the latter is localized to the LA or the RA. To further analyze the correspondence 
between intracardiac and surface AF frequencies in the RA and LA we grouped the 
intracardiac DFmax values measured in the LA and RA and correlated them with the DFs of 
EGMs from matching portions on the body surface. These matching portions were defined 
as those in which the difference between the intracardiac DFmax in each atrium and the 
surface DFmax was ≤0.5 Hz. Panels C and D of Figure 3 show that when the entire patient 
population under study was included, there was a good correspondence between maximum 
DFs found in each atrial chamber and right and left matching portions of the body surface, 
respectively. The correlation between right surface leads and right intracardiac EGMs was 
0.96, whereas correlation for left leads with left intracardiac EGMs was 0.92 (Figure 3E and 
3F). The attempted correlation of surface leads with EGMs of the opposed atrial chamber 
yielded much lower correlation values (RA body surface leads vs intracardiac LA EGMs, 
0.26; one tail t-test after Fisher r-to-z transform: p<0.0001 vs. r=0.96; left body surface leads 
vs intracardiac RA EGMs, 0.46; p=0.0052 vs. r=0.92).
Such a strong, side-specific correspondence of frequencies enabled reliable determination of 
atrial frequency gradients non-invasively.29The DF gradients on the 64 electrodes of the 
BSPM showed a good correlation with the DF gradients obtained by the simultaneous 
intracardiac EGMs (correlation coefficient = 0.93). On the other hand, surface frequency 
gradients estimated by the standard precordial ECG leads yielded a poor correspondence 
with gradients estimated from the intracardiac EGMs, with a correlation coefficient equal to 
0.41 when considering all 6 standard leads, or equal to 0.51 when considering only V1 and 
V6 (p=0.0051 when compared with the correlation of the full BSPM DF gradients).27, 29
To predict the ability of the BSPM to detect intracardiac LA-to-RA DF gradients, we 
classified patients with a LA-RA gradient in DF (maximal right and left values differ by 
more than 0.5 Hz) versus without LA-RA gradient, otherwise. Overall, the sensitivity of the 
BSPM to capture intracardiac EGMs as having LA-RA gradient in DF was 75%, but the 
specificity of the BSPM in capturing those gradients was 100%. The sensitivity and 
specificity of the standard ECG leads V1 and V6 in detecting a LA-to-RA DF gradient were 
67% and 50% respectively. In other words, while the BSPM was able to identify most, but 
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not all, intracardiac DF gradients, each DF gradient identified by the BSPM was a true 
gradient as determined by the intracardiac recordings. Standard ECG leads, however, 
allowed the detection of a lower proportion of patients with LA-to-RA DF gradients as 
compared to all BSPM leads and also mistakenly identified LA-RA DF gradients that were 
not confirmed in the EGM recordings.
Surface mapping of atrial patterns of activity during AF
Surface phase maps of the unipolar voltage time-series recorded during AF show unstable 
patterns, as can be appreciated by the transient singularity points (SPs) seen in the maps 
from a sample patient presented in the left panel of Figure 4A.30 Long-lasting SPs were 
rarely observed during AF without band-pass filtering and those observed tended to drift 
erratically large distances in short time. However, after bandpass filtering of the potential 
signal around the HDF (6.8 Hz), surface phase maps showed more stable SPs for the same 
AF episode (Figure 4A, right panel). In Panel B the arrows connecting sequential activations 
in ECGs recorded around the SP in Figure 4A show a clear reentrant pattern which 
following HDF-filtering transformed into long-lasting rotational patterns with stable SPs. 
Considering data from all patients, stable SPs were found in unfiltered AF signals during 
8.3±5.7% of the time vs. 73.1±16.8% following HDF-filtered signals (p<0.01). The average 
SPs’ duration concomitantly increased following the HDF-filtering (160±43 vs. 342±138 
ms, p<0.01). At an average HDF of 9.2±2.3 (BSPM) or 9.3±2.0 (EGM) Hz, the latter 
corresponds to an average of 2.9±0.7 continuous rotations per SP observed in our cohort of 
14 patients.30 Many observed SPs drift and appear or disappear on the borders of the surface 
mapped area, or in the beginning and end of the periods analyzed, thus this average number 
of rotations represents a lower limit for their life span. Indeed, Figure 4C and Video 1 
(available online at http://www.cardiacep.theclinics.com/). show a rotor in the middle of the 
mapped area at the beginning of the period analyzed that after about 1400 ms disappears at 
the lower boundary of the area. After a period of fuzzy SP behavior in the posterior torso 
(see Video 1) for about 330 ms, an SP appears and remains in the mapped area for the rest of 
the analyzed period. This case shows that the actual life span of rotors could be longer than 
the conservative average life-span we calculate. Further evidence of atrial rotor drifting is 
provided by the simultaneous EGM recorded at the highest DF site (Figure 4E), which is 
unstable in intervals 1-4 and monomorphic at interval 4-5, which is consistent with the 
observed drifting on the torso surface.
Simulations to understand HDF band-pass filtering of AF patterns
The finding that the dynamics of the body surface SPs dramatically depends on the HDF-
filtering raises questions regarding the phase maps interpretation. Unfortunately, the ability 
to collect simultaneously electrical data in the atria and inside the torso volume and surface 
to make inferences between atrial activity and its manifestation on the body surface is 
limited, leading us to rely on computer simulations for guidance.
In Figure 5 a simulation with a LA–RA atrial model and the multi-spheres torso model is 
depicted. In this model there is a single functional rotor in the LA hemisphere turning at 7.2 
Hz while the RA hemisphere is passively activated at lower a frequency (3.9 Hz). Figure 2A 
shows the phase maps of three concentric layers between the epicardium (left) and the torso 
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surface (right) at various times. The phase maps become smoother toward the torso surface, 
reflecting the low-pass filter effect of the passive torso volume on the extracellular 
potentials. In the epicardial layer there is one stable SP at the location of the functional rotor 
(LA) that appears at similar positions in the outer layers, and another SP at the less stable 
wavebreak location at the interface between the faster LA and the slower RA. Azimuth and 
elevation of SPs detected on the surface are not preserved across layers, so the filament 
arising from the LA rotor exhibits a deflection in its trajectory to the torso. The deflection 
angle of the filaments before HDF-filtering is not stationary over time and, instead, the 
filament trajectory describes a cone. However, Figure 5B shows that HDF-filtering 
significantly reduces the filaments’ deflection and stabilizes them to follow a straight path 
from the epicardium to the surface. The simulations suggested that SPs arising at the 
interface between LA and RA as a consequence of abrupt changes in propagation direction 
that reached the outermost layer disappear after HDF-filtering since their activation 
frequencies did not match with the HDF.30 In addition, we notice that a mirror filament 
appears with opposite direction and chirality as compared to the true rotor originating at the 
SP on the LA epicardium. Indeed, following the attenuation of RA activation frequencies, 
potentials on the RA hemisphere are caused by the rotating electrical activity on the LA and 
observed from a contralateral point of view.
The torso as a low-pass filter for rotor activity
We further explore the behavior of filaments under more complex wave patternsresulting 
from a 50% LA area and 50% fibrotic area model.30 In this case epicardial activity consists 
of a LA rotor with a stable SP and a highlydisorganized activity with several unstable SPs in 
the fibrotic area. Most of the filaments originate at SPs involving a small piece of fibrotic 
tissue and not at the driving rotor. In that case the torso volume conductor stabilizes 
filaments and eliminates all but a single filaments’ pair reaching the surface. Our 
simulations clearly show that filaments are continuous and do not vanish inside the passive 
volume conductor, rather a filament does not reach the surface once it is joining its counter-
rotating neighbor. Overall, that mutual cancelation of filament pairs reduces the average 
number of SPs at increasing distances from the epicardium.
But as shown in Figure 5, only one of the SPs on the body surface is a “true” SP 
corresponding to a driving rotor, and others are termed “mirror” SPsas they appear 
following the extinction of an SP at the LA-RA interface as shown in Figure 5, or extinction 
of SPs in fibrotic area, with an extension of the stable LA rotor filament to the contralateral 
aspect of the torso.30 Indeed, the discrimination between true and mirror SPs can be 
performed based on the spectral properties of surface recordings. Although on the phase 
map these SPs seem undistinguishable; the spectral power at the HDF, the rotor frequency 
band,should be maximal only at “true” SPs.30
Regions of body surface rotational activity in human AF (filaments)
True SPs detected, defined as those with at least 60% of their spectral content at the HDF 
band, tended to concentrate at certain torso areas. In Figure 6A, the trajectory of a surface 
SP that drifted during 2 seconds on the posterior torso of a patient following LAHDF 
filtering (band-pass filtering at the HDF found in simultaneous left intracardiac EGMs 
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recordings) is depicted (see Video 1). In Figure 6B the trajectory of a SP that drifted during 
500 ms on the right anterior torso in another patient after RA-HDF filtering is shown (see 
Video 2, available online at http://www.cardiacep.theclinics.com/). In Figure 6C, the 2-
dimensional histogram of “true” SP locations after LA-HDF filtering in patients with an 
inter-atrial DF gradient>1 Hz (n=10) shows a predominant location of SPs on the posterior 
torso. The 2-dimensional histogram of “true” SP locations after RAHDF filtering in patients 
with inter-atrial DF gradient shows a predominant localization on the right anterior torso, 
Figure 6D. The locations of the maximal numbers of true LA or RA SPs (dark red regions) 
are shown in Panels C and D to reside well within the areas demarcated by the HDFs 
originating either at the LA or RA, respectively, based on our previous surface-atrial DF 
distribution correlation study.29
Conclusion and Clinical Implications
Global atrial non-invasive frequency analysis is feasible in AF patients and may allow the 
identification of high frequency sources prior to the arrival at the electrophysiology 
laboratory for ablation. Importantly, our results lead to the conclusion that, unlike high-
resolution BSPM, the standard precordial ECG leads alone are not a useful tool when 
attempting to localize the site of DFmax sites responsible for AF maintenance.
Our clinical-computational BSPM study on patterns of activity suggests that the body 
surface data on wavebreaks during AF is incomplete, but it contains features that can be 
linked to reentrant drivers of AF. We developed an approach whereby a narrow band-pass 
filtering allows selecting the electrical activity projected on the torso at the HDF, which 
stabilizes the projection of rotors that potentially drive AF on the surface. Phase maps of 
HDF-filtered surface ECG recordings may allow the noninvasive localization of atrial re-
entries during AF, enabling further physiologically-based rationale for considering the 
constraints of the inverse solutions.
Thus, our approach of a full panoramic BSPM procedure may help in planning and 
performing ablation procedures, decreasing the amount of time required for the search of AF 
drivers. The approach could arguably be used in patient selection since patients without 
inter-chamber DF gradient or clear localized drivers have lower ablation success rates.17 
Additionally, a priori knowledge of the chamber responsible of the maintenance of the 
arrhythmia in those patients presenting a DF gradient may help in planning and performing 
the ablation procedure, decreasing the time required for the search and elimination of drivers 
and/or the highest DF site.
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Refer to Web version on PubMed Central for supplementary material.
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• Atrial fibrillation (AF) maintenance in experiments and certain groups of 
patients depends on localized reentrant sources with fibrillatory conduction to 
the remainder of the atria.
• AF can be eliminated by directly ablating AF-driving sources or “rotors” that 
exhibit high-frequency, periodic activity.
• The RADAR-AF randomized clinical trial demonstrated that in paroxysmal AF 
patients, selective ablation of highest frequency sites responsible for AF 
maintenance is as effective as CPVI, and decreased ablation risks.
• Body surface potential map dominant frequency estimation allows the global 
identification of high-frequency sources driving AF before and during the 
electrophysiology laboratory procedure for ablation.
• Phase maps of HDF-filtered BSPM recordings allow prior and real-time 
noninvasive localization of atrial re-entries during AF, enabling further 
physiologically-based rationale for personalized AF ablation procedures.
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The setup of the body surface recording electrodes. (A) Anterior and posterior views of the 
custom-made vest with 64 recording electrodes along vertical blue strips. (B) Schematic 
location of surface electrodes. Circles represent the location of recording electrodes. 
Electrodes representing the standard ECG precordial leads are denoted as black circles. (C) 
X-ray image displaying the locations of the intracardiac recording catheters together with 
the surface leads. Abl: ablation catheter; PV: Circular mapping at the right superior 
pulmonary vein; RA: right atrium; CS: coronary sinus. (From Guillem MS, Climent AM, 
Millet J, et al. Noninvasive localization of maximal frequency sites of atrial fibrillation by 
body surface potential mapping. Circulation. Arrhythmia and electrophysiology. 
2013;6:294-30; with permission.)
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Recorded EGMs and ECGs and their DF distribution in a sample patient with a left-to-right 
DF gradient. (A) Three examples of EGMs recorded at different atrial sites and their 
corresponding power spectra. (B) Selected surface BSPM leads: Surface Left (SL), Surface 
Posterior (SP) and Surface Right (SR), and their corresponding power spectra. (C) 
Intracardiac DF map. Black arrow points to the LA region with highest DF at the LSPV. (D) 
DF map on the torso surface with superimposed locations of electrodes from (B). (From 
Guillem MS, Climent AM, Millet J, et al. Noninvasive localization of maximal frequency 
sites of atrial fibrillation by body surface potential mapping. Circulation. Arrhythmia and 
electrophysiology. 2013;6:294-30; with permission.)
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Correspondence between intracardiac and surface dominant frequency (DFs). (A,B) 
Differences between maximum intracardiac eletrogram (EGM) DF and local surface DF 
represented in a color scale for two different patients. The red color domain on the surface 
(white arrows) represents the region with zero difference between the intracardiac and 
surface DFs. (A)Patient from Figure 2 with a left-to-right DF gradient.(B) Patient with a 
right-to-left DF gradient.(C,D) Summary maps showing the percent patients with the surface 
DFs less than 0.5 Hz different than the maximal left (C) and maximal right (D) intracardiac 
DFs. Areas outlined by the dashed curves represent the portion of the torso with a best 
correspondence with left and right EGMs. (E) Correlation plot showing highest DFs found 
in left EGMs vs. highest DFs found on the left portion of the torso. (F) Correlation plot 
showing highest DFs found in right EGMs vs. highest DFs found on the right portion of the 
torso. (From Guillem MS, Climent AM, Millet J, et al. Noninvasive localization of maximal 
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frequency sites of atrial fibrillation by body surface potential mapping. Circulation. 
Arrhythmia and electrophysiology. 2013;6:294-30; with permission.)
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Surface phase maps during AF. (A) Surface phase maps at three selected times for unfiltered 
(left) and for HDF-filtered (right) surface potentials. (B) ECGs at positions 1-6 marked in 
panel A before and after HDF-filtering and Power Spectral Density (PSD) for unfiltered 
ECGs. Time marker at 2656 ms corresponds to the top map in the HDF-filtered data in panel 
A. (C) PSs trajectories on the torso surface during a 3-sec long AF. (D) Percentage of time 
with rotors (up) and rotor duration (down) in surface phase maps from unfiltered and HDF-
filtered surface potentials over the entire cohort. (E) Electrogram recorded at the highest DF 
site in the atria (RSPV) simultaneously with the surface recordings. (From Rodrigo M, 
Guillem MS, Climent AM, et al. Body surface localization of left and right atrial high-
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frequency rotors in atrial fibrillation patients: A clinical-computational study. Heart Rhythm 
2014; 11(9):1584–91;with permission.)
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Epicardial and transition to surface phase maps during AF in a 50% LA–50% RA atrial 
model. (A) Phase maps at 4 time instants (top to down) in 3 concentric layers at increasing 
distances from the epicardium (left to right) and after HDF filtering of surface potentials. (B) 
Phase map of epicardial sphere and temporal distribution of filaments for unfiltered 
potentials and for HDF-filtered potentials. (Adapted from Rodrigo M, Guillem MS, Climent 
AM, et al. Body surface localization of left and right atrial high-frequency rotors in atrial 
fibrillation patients: A clinical-computational study. Heart Rhythm 2014; 11(9):1584–
91;with permission.)
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Spatial distribution of surface rotors in human AF. (A) Phase map and rotor tracking (blue 
scale) after LA-HDF filtering in an LA-fastest patient. (B) Phase map and rotor tracking 
(blue scale) after RA-HDF filtering in an RA-fastest patient. (C) Histogram of the rotor 
position for all rotors detected in patients with an inter-atrial DF gradient after LA-HDF 
filtering. LA-detected region is outlined with a dotted line. (D) Histogram of the rotor 
position for all rotors detected in patients with an inter-atrial DF gradient after RA-HDF 
filtering. RA-detected region is outlined with a dotted line. (From Rodrigo M, Guillem MS, 
Climent AM, et al. Body surface localization of left and right atrial high-frequency rotors in 
atrial fibrillation patients: A clinical-computational study. Heart Rhythm 2014; 11(9):1584–
91;with permission.)
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